We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$67.5M
Cap. Flow
-$16.8M
Cap. Flow %
-1.57%
Top 10 Hldgs %
43.59%
Holding
2,793
New
103
Increased
1,023
Reduced
644
Closed
145

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.03M
2
SNAP icon
Snap
SNAP
+$4.75M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$1.11M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.09M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$1.03M

Top Sells

Rank Stock Value
1
GBDC icon
Golub Capital BDC
GBDC
+$15.8M
2
NVDA icon
NVIDIA
NVDA
+$3.72M
3
COIN icon
Coinbase
COIN
+$2.93M
4
AVGO icon
Broadcom
AVGO
+$2.69M
5
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$1.89M

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Financials 13.81%
3 Healthcare 6.79%
4 Consumer Discretionary 3.87%
5 Communication Services 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBIO icon
1351
BridgeBio Pharma
BBIO
$16.5B
$15.3K ﹤0.01%
496
+72
+17% +$2.45K
HDV
1352
iShares Core High Dividend ETF
HDV
$14.8B
$15.3K ﹤0.01%
695
– –
MSM icon
1353
MSC Industrial Direct
MSM
$6.86B
$15.2K ﹤0.01%
157
+34
+28% +$3.33K
HBNC icon
1354
Horizon Bancorp
HBNC
$1.04B
$15.2K ﹤0.01%
1,184
+415
+54% +$5.29K
ETSY icon
1355
Etsy
ETSY
$7.85B
$15.2K ﹤0.01%
221
+50
+29% +$3.59K
TRUP icon
1356
Trupanion
TRUP
$1.18B
$15.2K ﹤0.01%
549
– –
PTCT icon
1357
PTC Therapeutics
PTCT
$6.12B
$15.2K ﹤0.01%
521
– –
IDT icon
1358
IDT Corp
IDT
$1.62B
$15.1K ﹤0.01%
400
– –
MUSA icon
1359
Murphy USA
MUSA
$9.61B
$15.1K ﹤0.01%
36
– –
SNN icon
1360
Smith & Nephew
SNN
$12.6B
$15.1K ﹤0.01%
594
-57
-9% -$1.56K
VMBS icon
1361
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.7B
$15.1K ﹤0.01%
330
-25
-7% -$1.14K
HAE icon
1362
Haemonetics
HAE
$4B
$15K ﹤0.01%
176
-45
-20% -$3.53K
NTLA icon
1363
Intellia Therapeutics
NTLA
$1.67B
$15K ﹤0.01%
546
-59
-10% -$1.64K
CVAC
1364
DELISTED
CureVac
CVAC
$14.9K ﹤0.01%
4,915
+3,539
+257% +$12.4K
EXPO icon
1365
Exponent
EXPO
$3.24B
$14.9K ﹤0.01%
180
+140
+350% +$11.6K
CBZ icon
1366
CBIZ
CBZ
$2.96B
$14.8K ﹤0.01%
189
– –
FRSH icon
1367
Freshworks
FRSH
$3.27B
$14.8K ﹤0.01%
812
– –
VIR icon
1368
Vir Biotechnology
VIR
$1.49B
$14.7K ﹤0.01%
1,455
+214
+17% +$2.18K
LNT icon
1369
Alliant Energy
LNT
$18B
$14.7K ﹤0.01%
292
+12
+4% +$589
IPGP icon
1370
IPG Photonics
IPGP
$3.84B
$14.6K ﹤0.01%
161
+145
+906% +$13.6K
AZEK
1371
DELISTED
The AZEK Co
AZEK
$14.5K ﹤0.01%
289
+67
+30% +$2.92K
HHH icon
1372
Howard Hughes
HHH
$4.03B
$14.5K ﹤0.01%
209
– –
TTEC icon
1373
TTEC Holdings
TTEC
$124M
$14.4K ﹤0.01%
1,391
+842
+153% +$14.1K
UHS icon
1374
Universal Health Services
UHS
$10.5B
$14.4K ﹤0.01%
79
– –
VIAV icon
1375
Viavi Solutions
VIAV
$9.66B
$14.3K ﹤0.01%
1,576
+861
+120% +$8.45K
53 54
55
56 57

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Lindbrook Capital held 2,793 positions worth $1.07B, up 6.7% from $1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Lindbrook Capital's Q1 2024 filing shows 103 new, 1,023 increased, 644 reduced and 145 closed positions. Its largest new stake was Hess Midstream: 14,335 shares worth $518K. The largest sale was Golub Capital BDC, an estimated $15.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Lindbrook Capital's largest Q1 2024 buy was Hess Midstream: 14,335 shares worth $518K.
  • Lindbrook Capital added most to Vertex Pharmaceuticals in Q1 2024, an estimated $8.03M increase.
  • Lindbrook Capital's biggest Q1 2024 reduction was Golub Capital BDC, cutting an estimated $15.8M.
  • Lindbrook Capital fully exited Splunk Inc in Q1 2024, selling an estimated $153K.
  • Lindbrook Capital's ten largest holdings make up 44% of its $1.07B portfolio in Q1 2024.
  • Lindbrook Capital opened 103 new positions and closed 145 in Q1 2024.
  • Lindbrook Capital's portfolio value rose 6.7% quarter-over-quarter to $1.07B.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.